treating complex heart rhythm disorder

Royal Philips Electronics recently announced an agreement with Bard Electrophysiology, a division of C. R. Bard, Inc., to co-develop new clinical tools, which will be designed to help electrophysiologists and aid patients suffering from arrhythmias.
The goal of of Bard’s LabSystemTMPRO EP recording system and Philips’ EP navigator and Allura Xper FD series is to provide electrophysiologists a faster and easier way to integrate image guidance with mapping and analysis of complex arrhythmias, while offering insights for more accurate interventional navigation. EP physicians and lab staff may also benefit from improved workflow in the EP lab due to integration and compatibility between Philips and Bard technologies.
Heart rhythm disorders or arrhythmias require
electrophysiology (EP) technologies to pinpoint and ultimately fix problem areas within the heart’s electrical circuitry during an interventional procedure. Atrial fibrillation, a heart rhythm disorder characterised by irregular, rapid beating of the atrial chambers, is found in about 2.2 million Americans and 4.5 million Europeans. With robust EP technologies, clinicians may be better able to evaluate and diagnose abnormalities in the heart’s electrical activity. Meanwhile, Royal Philips Electronics and Hansen Medical, Inc. recently signed joint development and cooperation agreements to co-develop integrated products that may simplify complex cardiac procedures to diagnose and treat irregular heartbeats.